Glenmark Pharmaceuticals Limited is a Overseas Corporation, established on 20 Oct 2015 and registered in 2D/7A, MYINT ZU (2) STREET, PARAMI ROAD, YANKIN TOWNSHIP, YANGON, MYANMAR. The MyCO registration number is 111744823 and the recorded activities include 21 - manufacture of basic pharmaceutical products and pharmaceutical preparations. Glenmark Pharmaceuticals Limited has been operating for 10 years and its current status is Registered.
Profile
Company DetailsCompany record
- Legal name
- Glenmark Pharmaceuticals Limited
- Local name
- GLENMARK PHARMACEUTICALS LIMITED (MYANMAR BRANCH OFFICE)
- Registration number
- 111744823
- Prior registration number
- 604FC/2015-2016(YGN)
- Entity type
- Overseas Corporation
- Status
- Registered
- Registered date
- 20 Oct 2015
- Total shares
- 0
- Business activities
- 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
- Holding company
- IND
- Filing dates
- Annual return due 28 Apr 2021 Β· Financial statement due 31 Dec 2020
Contact DetailsRegistered contact information
- Registered address
- 2D/7A, MYINT ZU (2) STREET, PARAMI ROAD, YANKIN TOWNSHIP, YANGON, MYANMAR
- Postal address
- Not stated in the MyCO record
- Telephone
- Lockedπ
- Email
- Lockedπ
People
ManagementRecorded directors and officers
- BERNARD H. MUNOSDirector Β· United States of America
- BLANCHE E SALDANHADirector Β· India
- BRIAN W. TEMPESTDirector Β· United Kingdom
- CHERYLANN PINTODirector Β· India
- D. R. MEHTADirector Β· India
- GLENN SALDANHADirector Β· India
- JULIO FRANCIS RIBEIRODirector Β· India
- MILIND SARWATEDirector Β· India
- RAJESH V. DESAIDirector Β· India
- SRIDHAR GORTHIDirector Β· India
- V S MANIDirector Β· India
- DEEPAK KHEDKARAuthorised Officer Β· India
ShareholderShareholding of Glenmark Pharmaceuticals Limited
Ownership records and shareholder relationships require premium access.
- βShareholder names and holdings
- βOwnership percentages and changes
Financial
Credit RatingCredit rating for Glenmark Pharmaceuticals Limited
Credit assessment and supporting financial indicators require premium access.
- βCredit rating and payment profile
- βFinancial strength and risk indicators
Risk
Government ConnectionGovernment connection checks for Glenmark Pharmaceuticals Limited
Government ownership, control, and politically exposed person links require premium access.
- βGovernment ownership and control checks
- βPolitically exposed person links
LitigationLitigation checks for Glenmark Pharmaceuticals Limited
Court records and material dispute intelligence require premium access.
- βCivil and commercial court records
- βCase status and material outcomes
RegulatoryRegulatory checks for Glenmark Pharmaceuticals Limited
Regulatory actions, sanctions, and compliance findings require premium access.
- βRegulatory actions and sanctions
- βLicence and compliance findings
Adverse MediaAdverse media checks for Glenmark Pharmaceuticals Limited
Source-screened media coverage and reputational risk signals require premium access.
- βSource-screened media coverage
- βMaterial allegations and reputational signals